Article

TGFβ1 and RGD Cooperatively Regulate SMAD 2/3 Mediated Oncogenic Effects in Prostate…

medRxiv · 2024 · Pol, M.; Gao, H.; Fox, j.; Jia, X.

Key facts

Title TGFβ1 and RGD Cooperatively Regulate SMAD 2/3 Mediated Oncogenic Effects in Prostate Cancer Cells in Bioorthogonally Constructed Hydrogels
First author Pol, M.; Gao, H.; Fox, j.; Jia, X.
Journal medRxiv
Published Jan 1, 2024
DOI 10.1101/2024.12.09.627597
Devices mentioned BK110039, K103302, K800552, K853723, K860811, K862004, K874160, K874609, K912581, K915561, K915840, K920529 and 12 more
Product codes mentioned EPT, GCJ, GCT, GEX, HET, HJO, HLI, HLQ, HQF, KKX, NDS, PCA and 3 more

At a glance

  • 10–99 FDA submissions mentioned
  • 10–99 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature